Skip to main content
Premium Trial:

Request an Annual Quote

Cellink: Ido Amit

Cellink said that Ido Amit is joining the company's scientific advisory board. Amit is a researcher in the Immunology Department at the Weizmann Institute of Science in Israel, where he also earned his PhD in biological regulation. He was a postdoctoral fellow at the Broad Institute at Harvard University and the Massachusetts Institute of Technology. Amit's expertise is in the area of single-cell genomic technologies and their application to characterize the immune system, and as such he will guide Cellink's efforts to build a strong product portfolio for single-cell omics analysis, the company said.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.